Zoom Communications (ZM) is a Top-Ranked Growth Stock: Should You Buy? — Positive
ZM Zacks Investment Research — December 23, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Braze: The Rebound Is Just Beginning As Revenue Accelerates — Positive
BRZE Seeking Alpha — December 23, 2025Braze is positioned as a top rebound candidate among small- and mid-cap growth stocks for 2026. BRZE's enterprise focus is driving ~30% y/y growth in $500k+ ARR customers, supporting a bullish outlook. AI-driven marketing solutions and international expansion—now ~45% of revenue—are accelerating BRZE's growth trajectory.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of StubHub — Neutral
STUB PRNewsWire — December 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In StubHub To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of StubHub pursuant and/or traceable to StubHub's registration statement for the initial public offering held on or about September 17, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law …
Zebra Technologies: Deep Value And Positive Market Outlook — Positive
ZBRA Seeking Alpha — December 23, 2025We believe Zebra Technologies is deeply undervalued after a 36% stock decline despite robust fundamentals. Zebra's expanding distributor network and channel partner programs have strengthened global reach and driven revenue growth, especially through top three distributors. Favorable macro trends in healthcare and retail, coupled with accelerating RFID adoption, position the company for sustained growth in its core AIDC market.
Palvella Therapeutics: Phase 2 Success De-Risks 2026 Catalyst — Positive
PVLA Seeking Alpha — December 23, 2025Palvella Therapeutics offers a compelling risk/reward profile, underpinned by strong Phase 2 data and a pivotal Phase 3 catalyst in Q1 2026. Palvella's QTORIN rapamycin platform demonstrates high local efficacy with minimal systemic exposure, validated across multiple rare skin disease indications. With $63.6M in cash and a recent $80M raise, Palvella is well-capitalized to reach key data readouts and NDA preparation, minimizing financing risk.
Musk warned years ago about Tesla door handle safety risks: report — Negative
TSLA Proactive Investors — December 23, 2025Elon Musk was warned nearly a decade ago about potential safety risks tied to Tesla Inc (NASDAQ:TSLA)'s electrically powered exterior door handles, according to a report by Bloomberg, as the automaker now faces heightened regulatory scrutiny over door-related safety issues. Bloomberg, citing anonymous sources familiar with internal discussions, reported that concerns about electric door handle failures were raised to Musk during production of the Model 3.
JHX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In JHX To Contact Him Directly To Discuss Their Options — Neutral
JHX PRNewsWire — December 23, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In James Hardie To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in James Hardie between May 20, 2025 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie …
FCPT Continues With Expansionary Efforts, Buys Applebee's Property — Positive
FCPT Zacks Investment Research — December 23, 2025Four Corners expands its net-lease portfolio with Applebee's and veterinary property buys, reinforcing diversification while pursuing long-term growth.
Is Grupo Cibest S.A. - Sponsored ADR (CIB) Stock Outpacing Its Conglomerates Peers This Year? — Positive
CIB Zacks Investment Research — December 23, 2025Here is how Grupo Cibest (CIB) and ITT (ITT) have performed compared to their sector so far this year.
Are Investors Undervaluing Aveanna Healthcare (AVAH) Right Now? — Positive
AVAH Zacks Investment Research — December 23, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Astrazeneca (AZN) is a Strong Value Stock — Positive
AZN Zacks Investment Research — December 23, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Ingredion (INGR) Stock Undervalued Right Now? — Positive
INGR Zacks Investment Research — December 23, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Suncor Energy (SU) Stock? — Positive
SU Zacks Investment Research — December 23, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why CDW (CDW) is a Top Value Stock for the Long-Term — Positive
CDW Zacks Investment Research — December 23, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Powell Industries (POWL) Stock Outpacing Its Industrial Products Peers This Year? — Positive
POWL Zacks Investment Research — December 23, 2025Here is how Powell Industries (POWL) and Proto Labs (PRLB) have performed compared to their sector so far this year.
Has Canadian Imperial Bank of Commerce (CM) Outpaced Other Finance Stocks This Year? — Positive
CM Zacks Investment Research — December 23, 2025Here is how Canadian Imperial Bank (CM) and DNB Bank ASA (DNBBY) have performed compared to their sector so far this year.
Why Flex (FLEX) is a Top Value Stock for the Long-Term — Positive
FLEX Zacks Investment Research — December 23, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Investors Undervaluing AES (AES) Right Now? — Positive
AES Zacks Investment Research — December 23, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Utilities Stocks Lagging Ballard Power Systems (BLDP) This Year? — Negative
BLDP Zacks Investment Research — December 23, 2025Here is how Ballard Power Systems (BLDP) and MYR Group (MYRG) have performed compared to their sector so far this year.
Is Digi International (DGII) Stock Outpacing Its Computer and Technology Peers This Year? — Positive
DGII Zacks Investment Research — December 23, 2025Here is how Digi International (DGII) and IBM (IBM) have performed compared to their sector so far this year.